Table 1 Gender-wise baseline characteristics of the study subjects.
Variables | Total | Male | Female | p-value |
|---|---|---|---|---|
Number, n (%) | 325 | 234 (72%) | 91 (28%) | – |
Age (years) | 43.6 ± 12.7 (85.0) | 43.1 ± 12.6 (85.0) | 44.8 ± 12.7 (71.0) | 0.260 |
Weight (kg) | 65.2 ± 11.6 (105.0) | 67.9 ± 10.6 (105.0) | 58.2 ± 11.0 (90.0) | 0.000 |
Height (cm) | 92.8 ± 78.9 (181.0) | 97.0 ± 80.2 (181.0) | 81.9 ± 75.0 (160.0) | 0.112 |
BMI (kg/m2) | 25.2 ± 3.7 (40.0) | 25.0 ± 3.4 (39) | 25.7 ± 4.4 (40.0) | 0.175 |
WC (cm) | 86.6 ± 10.3 (116.0) | 87.6 ± 10.0 (116.0) | 84.3 ± 10.5 (113.0) | 0.023 |
HC (cm) | 91.7 ± 8.1 (113.0) | 92.0 ± 8.0 (113.0) | 90.8 ± 8.3 (113.0) | 0.290 |
SBP (mmHg) | 129.9 ± 17.7 (216.0) | 129.8 ± 17.5 (216.0) | 130.1 ± 18.4 (190.0) | 0.906 |
DBP (mmHg) | 84.3 ± 9.7 (118.0) | 84.1 ± 9.9 (118.0) | 84.6 ± 9.3 (112.0) | 0.667 |
PP (Beats/min) | 79.5 ± 12.0 (124.0) | 78.1 ± 12.1 (122.0) | 82.7 ± 11.1 (124.0) | 0.004 |
FBG (mmol/L) | 8.1 ± 4.4 (26.9) | 7.8 ± 4.4 (26.9) | 9.0 ± 4.2 (26.4) | 0.024 |
XO (U/L) | 4.5 ± 3.2 (18.9) | 4.0 ± 2.8 (17.4) | 6.0 ± 3.7 (18.9) | 0.000 |
SUA (mg/dL) | 5.6 ± 2.0 (12.9) | 6.1 ± 1.9 (12.9) | 4.4 ± 1.9 (9.9) | 0.000 |
Creatinine (mg/dL) | 0.9 ± 0.3 (2.5) | 0.9 ± 0.3 (2.5) | 0.7 ± 0.3 (2.3) | 0.000 |
eGFR (mL/min/1.73 m2) | 89.5 ± 18.8 (149.1) | 90.1 ± 18.9 (147.0) | 87.6 ± 18.6 (149.1) | 0.371 |
SA(g/L) | 45.3 ± 11.1 (94.4) | 46.8 ± 11.2 (94.4) | 41.1 ± 9.8 (68.4) | 0.007 |
TG (mg/dL) | 202.7 ± 123.2 (812.6) | 202.2 ± 119.7 (726.6) | 203.8 ± 132.4 (812.6) | 0.920 |
TC (mg/dL) | 219.5 ± 87.7 (584.0) | 213.0 ± 81.6 (561.9) | 236.5 ± 100.2 (584.0) | 0.041 |
HDL (mg/dL) | 34.6 ± 13.4 (112.4) | 34.0 ± 14.2 (112.4) | 36.4 ± 10.9 (67.8) | 0.172 |
LDL (mg/dL) | 145.6 ± 81.9 (517.2) | 139.5 ± 72.3 (514.9) | 161.3 ± 101.3 (517.2) | 0.079 |
Diabetes (%) | 53.2 | 45.3 | 73.6 | – |
